French agro-industrial group Avril and Dutch science-based firm Royal DSM plan to work together to produce a non-genetically modified (GM) protein-based canola to meet growing consumer demand.
DSM said in a statement on 8 July that the canola had a high nutritional value and balanced taste profile, making it ideal for a range of applications such as meat and dairy alternatives, beverages, baked products, bars and ready-to-mix.
Avril CEO Jean-Philippe Puig said: “With 10bn inhabitants by 2050, experts predict global demand for both animal and plant-based protein to grow, with exponential growth in plant-based proteins due to dietary shifts.”
“More people are opting for flexitarian, vegetarian and vegan diets for personal, health and environmental reasons,” said Trish Malarkey, chief innovation officer for DSM.
“With our expertise, DSM can support all forms of proteins produced to the highest sustainable standards. With Avril as a partner, we will be uniquely positioned to serve this growing market and look forward to helping our customers deliver great tasting, healthy, and sustainable food and beverages.”
The two companies planned to develop a production facility fully dedicated to canola proteins at Avril’s Saipol facility in Dieppe, France.
DSM said the ingredient could be available commercially as early as the end of 2021.